PT - JOURNAL ARTICLE AU - Wickstrom, Jordan AU - Dell’Armo, Kristin AU - Salzman, Emma AU - Hooker, Jessica L. AU - Delehanty, Abigail AU - Bishop, Somer AU - Tassé, Marc J. AU - Wetherby, Amy M. AU - Piergies, Antonia M. H. AU - Damiano, Diane AU - Rauch, Alexandra AU - Thurm, Audrey TI - Systematic Review: Recommendations for Rehabilitation in ASD and ID from Clinical Practice Guidelines AID - 10.1101/2021.04.05.21254892 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.05.21254892 4099 - http://medrxiv.org/content/early/2021/04/07/2021.04.05.21254892.short 4100 - http://medrxiv.org/content/early/2021/04/07/2021.04.05.21254892.full AB - Objective Autism spectrum disorder (ASD) and intellectual disability (ID) were selected for inclusion in the development of a Package of Interventions for Rehabilitation for the World Health Organization (WHO). Here, we describe results of a search of guidelines for these conditions.Methods A literature search for clinical practice guidelines was performed for ASD and ID. Using the Appraisal of Guidelines for Research and Evaluation instrument and other inclusion and exclusion criteria, guidelines were identified for abstraction of recommendations, which were collated into categories based on diagnosis, patient age, type and target of service, valence, and level of evidence.Results Six guidelines remained after screening. Four ASD guidelines focused on diagnosis, management and support, and two ID guidelines covered the prevention, assessment, and management of challenging behavior and mental health problems, with 386 and 138 recommendations resulting for each group, respectively. Out of 524 total recommendations, 212 ASD and 58 ID recommendations focused on intervention. The primary type of intervention pertained to pharmacology for each group (27% ASD, 29% ID), followed by psychosocial (21%) and biomedical (23%) for ASD and behavioral (14%) and psychological (14%) for ID. Regarding target of intervention, recommendations primarily focused on coexisting conditions for each group (56% ASD, 93% ID) and core symptoms for ASD (26%), whereas adaptive functioning received little attention (11% ASD, 7% ID).Conclusions Although these six guidelines provided many recommendations for comorbid and specific problems in ASD and ID, very few recommendations targeted core symptoms, and many were based on expert opinion. A vital next step includes identifying relevant interventions from the guidelines or that are missing to be included in the WHO Package of Interventions for Rehabilitation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported (in part) by the Intramural Research Program of the NIMH (1ZICMH002961).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a systematic review that included the following 6 guidelines (with links): National Institute for Health and Care Excellence (NICE). Autism spectrum disorder in under 19s: support and management. Clinical guideline CG170. NICE. https://www.nice.org.uk/guidance/cg170. Published 2013. Accessed. National Institute for Health and Care Excellence (NICE). Autism spectrum disorder in adults: diagnosis and management. Clinical guideline CG142. NICE. https://www.nice.org.uk/guidance/cg142. Published 2012. Accessed. National Institute for Health and Care Excellence (NICE). Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. NICE guideline NG11. NICE. https://www.nice.org.uk/guidance/ng11. Published 2015. Accessed. National Institute for Health and Care Excellence (NICE). Mental health problems in people with learning disabilities: prevention, assessment and management. NICE guideline NG54. NICE. https://www.nice.org.uk/guidance/ng54. Published 2016. Accessed. Scottish Intercollegiate Guidelines Network (SIGN). Assessment, diagnosis and interventions for autism spectrum disorders: A national clinical guideline. SIGN publication no. 145. SIGN. http://www.sign.ac.uk. Published 2016. Accessed. Veereman G, Holdt Henningsen K, Eyssen M, et al. Management of autism in children and young people: a good clinical practice guideline. KCE reports 233. Belgian Health Care Knowledge Centre (KCE). https://kce.fgov.be/report/233. Published 2014. Accessed. AGREE-IIAppraisal of Guidelines for Research and EvaluationASDAutism Spectrum DisorderIDIntellectual DisabilityWHOWorld Health Organization